The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer

被引:14
|
作者
Ostheimer, Christian [1 ]
Schweyer, Franziska [1 ]
Reese, Thomas [1 ]
Bache, Matthias [1 ]
Vordermark, Dirk [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany
关键词
NSCLC; osteopontin; radiotherapy; tumor volume; prognostic factors; RADIATION-THERAPY; PROGNOSTIC-FACTOR; NECK-CANCER; HYPOXIA MARKERS; SURVIVAL; HEAD; CHEMORADIOTHERAPY; OXYGENATION; EXPRESSION; VELOCITY;
D O I
10.3892/ol.2016.5104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic quality of increased osteopontin (OPN) plasma levels has been demonstrated for the chemotherapy and surgery of lung cancer. There is also evidence in the literature that tumor volume impacts prognosis in definitive radiotherapy (RT) of (lung) cancer. We previously demonstrated that elevated plasma levels of OPN before, and increasing OPN plasma levels after RT significantly correlate with survival and outcome after curative-intent RT of non-small-cell lung cancer (NSCLC). Tumor volume was also associated with prognosis. The present prospective clinical study investigated the prognostic interrelation of OPN plasma levels and tumor volume and their changes in the radical RT of NSCLC. We evaluated a subset of patients (n=27) with inoperable, non-metastasized NSCLC of the previously published patient collective. Patients were treated with radical radiochemotherapy (2 Gy ad 66 Gy). OPN plasma concentrations were determined by ELISA before (t0), at the end (t1), and 4 weeks after RT (t2). GTV was delineated PET- and CT-correlated before RT (GTV1) and after 40 Gy (GTV2). The course of OPN during and after RT and the change of GTV during RT was monitored over time and correlated with prognosis. Median GTV2 after 40 Gy (63 ml) was significantly lower than pre-RT GTV1 (90 ml, P<0.0001). Median OPN before (t0), at the end of (t1) and four weeks after RT (t2) was 846, 777 and 624 ng/ml and not significantly different. GTV significantly declined by 39 ml during RT (P<0.0001) and OPN non-significantly decreased by 56 ng/ml during (t0 to t1) and by 54 ng/ml after RT (t1 to t2). No correlations were determined between absolute OPN and GTV values or their relative changes during RT. In univariate analysis, only GTV2 significantly predicted overall survival (OS, P=0.03). In multivariate analysis, both OPN t1 (P<0.001) and GTV2 (P=0.001) remained significant predictors of OS. Relative OPN plasma level changes after (t1 to t2) and GTV changes during RT (GTV 1 to GTV 2) significantly predicted OS (P=0.02). The combination of absolute GTV values before RT (GTV1) and GTV changes during RT (GTV1 to 2) were significantly associated with OS in both uni- and multivariate analysis (P=0.03). The combination of absolute OPN plasma levels and their changes with GTV and its changes did not reach statistical significance. The lack of a significant correlation between OPN and GTV together with the finding that OPN and GTV remained independent predictors of survival outcome but were not associated with OS in combination supports the hypothesis that tumor volume (GTV) and OPN plasma levels (both their changes and absolute values) are not interrelated in terms of prognosis but do possess each parameter separately, a prognostic quality in the radical RT of NSCLC which justifies further prospective studies to validate these results.
引用
收藏
页码:3449 / 3456
页数:8
相关论文
共 50 条
  • [41] Palliative percutaneous radiotherapy in non-small-cell lung cancer
    Budach, W
    Belka, C
    LUNG CANCER, 2004, 45 : S239 - S245
  • [42] RADIOTHERAPY IN THE MANAGEMENT OF NON-SMALL-CELL LUNG-CANCER
    BEZJAK, A
    PAYNE, D
    WORLD JOURNAL OF SURGERY, 1993, 17 (06) : 741 - 750
  • [43] Relationship between vascularity, age and survival in non-small-cell lung cancer
    LM Chandrachud
    N Pendleton
    DM Chisholm
    MA Horan
    AM Schor
    British Journal of Cancer, 1997, 76 : 1367 - 1375
  • [44] DOSE-VOLUME COMPARISON OF PROTON RADIOTHERAPY AND STEREOTACTIC BODY RADIOTHERAPY FOR NON-SMALL-CELL LUNG CANCER
    Kadoya, Noriyuki
    Obata, Yasunori
    Kato, Takahiro
    Kagiya, Masaru
    Nakamura, Tatsuya
    Tomoda, Takuya
    Takada, Akinori
    Takayama, Kanako
    Fuwa, Nobukazu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1225 - 1231
  • [45] Modeling Tumor-Volume Variation During Fractionated Radiotherapy for Non-Small Cell Lung Cancer
    Chvetsov, A.
    Dong, L.
    Tucker, S.
    Palta, J.
    Mendenhall, N.
    MEDICAL PHYSICS, 2009, 36 (06)
  • [46] Modeling tumor and treated lung volume influences in the irradiation of non-small-cell lung cancer patients
    Abratt, RP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (02): : 481 - 485
  • [47] Intra-patient variability of tumor volume and tumor motion during radiotherapy for non-small cell lung cancer
    Dekker, A.
    Bosmans, G.
    van Baardwijk, A.
    Ollers, M.
    Boersma, L.
    Minken, A.
    Lambin, P.
    De Ruysscher, D.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S224 - S224
  • [48] Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer
    Voong, Khinh Ranh
    Hazell, Sarah Z.
    Fu, Wei
    Hu, Chen
    Lin, Cheng Ting
    Ding, Kai
    Suresh, Karthik
    Hayman, Jonathan
    Hales, Russell K.
    Alfaifi, Salem
    Marrone, Kristen A.
    Levy, Benjamin
    Hann, Christine L.
    Ettinger, David S.
    Feliciano, Josephine L.
    Peterson, Valerie
    Kelly, Ronan J.
    Brahmer, Julie R.
    Forde, Patrick M.
    Naidoo, Jarushka
    CLINICAL LUNG CANCER, 2019, 20 (04) : E470 - E479
  • [49] DETECTION OF CIRCULATING TUMOR CELLS AND EARLY RECURRENCE IN PATIENTS UNDERGOING RADICAL RESECTION FOR NON-SMALL-CELL LUNG CANCER
    Bayarri-Lara, C. I.
    Serrano, M. J.
    Giraldo, C. F.
    Ortega, F. G.
    Ruiz-Zafra, F. J.
    Sanchez-Palencia, A.
    Garcia-Puche, J. L.
    Delgado-Rodriguez, M.
    Navajas, J. A.
    Cueto, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [50] Optimization of volume in radiotherapy of non-small cell lung cancer: small volume
    Emami, B
    TREATMENT OPTIMIZATION FOR LUNG CANCER: FROM CLASSICAL TO INNOVATIVE PROCEDURES, 1998, : 59 - 65